Overall survival of CDK4/6-inhibitors-based treatments in clinically relevant subgroups of metastatic breast cancer: systematic review and meta-analysis
Journal of the National Cancer Institute ; doi:10.1093/jnci/djaa071
The publisher has not yet granted permission to display this abstract.
Keywords: overall survival / metastatic breast cancer / hormone therapy / hormone receptors / subgroup analysis / CDK4/6-inhibitors
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Click here to see the statistics on "Journal of the National Cancer Institute" .